• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后泌尿生殖系统恶性肿瘤

Malignancies of the genito-urinary system following renal transplantation.

作者信息

Schmidt R, Stippel D, Krings F, Pollok M

机构信息

Department of Surgery, University of Cologne, Germany.

出版信息

Br J Urol. 1995 May;75(5):572-7. doi: 10.1111/j.1464-410x.1995.tb07409.x.

DOI:10.1111/j.1464-410x.1995.tb07409.x
PMID:7613790
Abstract

OBJECTIVE

To analyse the development of malignancies of the genito-urinary system after renal transplantation.

PATIENTS AND METHODS

A total of 868 renal graft recipients were followed up over a mean period of 41.8 +/- 45 months. Fifteen patients received grafts from living related donors and 853 were transplanted with kidneys from cadavers.

RESULTS

Twelve patients (1.4%) exhibited cancer of the genito-urinary system: 11 tumours were de novo malignancies. One small renal carcinoma was transplanted from a living related donor. The incidence of tumours of the genito-urinary system was 34 in 100,000 patient years in the patients treated with cyclosporin and 32 in 100,000 patient years in the conventional therapy group. Four patients died within a mean survival time of 14.4 months. Comparison of our results with sex- and age-specific incidence rates in a reference population showed an increase in malignant tumours of the genitourinary system by a factor of 7.3 in males and 11.2 in females.

CONCLUSIONS

The frequency of disorders after transplantation necessitates routine examinations in organ transplanted recipients both before and at regular intervals after transplantation, including the patient's native kidneys and cervical smears in females.

摘要

目的

分析肾移植后泌尿生殖系统恶性肿瘤的发生情况。

患者与方法

对868例肾移植受者进行了平均41.8±45个月的随访。15例患者接受了亲属活体供肾移植,853例接受了尸体肾移植。

结果

12例患者(1.4%)出现泌尿生殖系统癌症:11例肿瘤为新发恶性肿瘤。1例小肾癌来自亲属活体供肾。环孢素治疗组泌尿生殖系统肿瘤的发病率为每10万患者年34例,传统治疗组为每10万患者年32例。4例患者在平均生存时间14.4个月内死亡。将我们的结果与参考人群中按性别和年龄划分的发病率进行比较,结果显示男性泌尿生殖系统恶性肿瘤发病率增加了7.3倍,女性增加了11.2倍。

结论

移植后疾病的发生频率表明,器官移植受者在移植前和移植后定期进行常规检查很有必要,包括检查患者的原生肾脏以及女性的宫颈涂片。

相似文献

1
Malignancies of the genito-urinary system following renal transplantation.肾移植后泌尿生殖系统恶性肿瘤
Br J Urol. 1995 May;75(5):572-7. doi: 10.1111/j.1464-410x.1995.tb07409.x.
2
Tumors after renal transplantation.
Urol Int. 1996;57(1):21-6. doi: 10.1159/000282871.
3
Urological malignancy after renal transplantation.肾移植后的泌尿系统恶性肿瘤
BJU Int. 2007 Sep;100(3):502-5. doi: 10.1111/j.1464-410X.2007.07049.x.
4
Genitourinary tumor following kidney transplantation: a multicenter study.肾移植后泌尿生殖系统肿瘤:一项多中心研究。
Transplant Proc. 2009 Sep;41(7):2848-9. doi: 10.1016/j.transproceed.2009.07.056.
5
Kidney transplantation in the United States.美国的肾脏移植
Clin Transpl. 2008:1-18.
6
Annual trends and triple therapy--1991-2000.1991 - 2000年的年度趋势与三联疗法
Clin Transpl. 2001:247-69.
7
Malignancy following renal transplantation.肾移植后的恶性肿瘤
Zhonghua Yi Xue Za Zhi (Taipei). 1998 May;61(5):281-8.
8
De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.肾移植受者的新发恶性肿瘤:39 年中在单一中心对 1882 例移植患者的经验
Clin Transplant. 2013 Jan-Feb;27(1):E30-6. doi: 10.1111/ctr.12050. Epub 2012 Dec 27.
9
Urological de novo malignancy after kidney transplantation: a case for the urologist.肾移植后新发尿路上皮癌:泌尿科医生的挑战
J Urol. 2011 Feb;185(2):428-32. doi: 10.1016/j.juro.2010.09.091. Epub 2010 Dec 17.
10
Incidence and treatment of malignant tumors of the genitourinary tract in renal transplant recipients.肾移植受者泌尿生殖道恶性肿瘤的发病与治疗。
Int Braz J Urol. 2018 Sep-Oct;44(5):874-881. doi: 10.1590/S1677-5538.IBJU.2017.0471.

引用本文的文献

1
Risk for cancer in living kidney donors and recipients.活体肾供体和受体患癌风险。
J Cancer Res Clin Oncol. 2018 Mar;144(3):543-550. doi: 10.1007/s00432-018-2590-z. Epub 2018 Jan 22.
2
Management of Bladder Cancer following Solid Organ Transplantation.实体器官移植后膀胱癌的管理
Adv Urol. 2011;2011:256985. doi: 10.1155/2011/256985. Epub 2011 Apr 18.
3
Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.中国肾移植受者原发性肾脏肾细胞癌:12 例报告及文献复习。
Int Urol Nephrol. 2011 Sep;43(3):675-80. doi: 10.1007/s11255-011-9912-2. Epub 2011 Mar 10.
4
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient.多学科治疗包括索拉非尼稳定了免疫抑制肾移植受者的肾癌骨转移。
Int J Clin Oncol. 2009 Oct;14(5):465-7. doi: 10.1007/s10147-008-0868-x. Epub 2009 Oct 25.
5
Cyclosporin-A associated malignancy.环孢素A相关恶性肿瘤。
Clin Ophthalmol. 2007 Dec;1(4):421-30.